Status:
COMPLETED
Exercise Intensity, Glycemic Control and Abdominal Fat in People With Type 2 Diabetes: A Pilot Study
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Alberta Diabetes Institute
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
55-75 years
Phase:
NA
Brief Summary
Body fat is an important risk factors for type 2 diabetes. However, not all body fat is the same. Research suggests that fat stored in the abdomen is most harmful. This is known as intra-abdominal fat...
Eligibility Criteria
Inclusion
- Men and women with type 2 diabetes.
- From 55-75 years of age (Women post-menopausal for at least 5 years).
- Sedentary: \< 3 bouts of planed physical activity of \>30 min per week.
Exclusion
- Smoking (defined as more than one cigarette per day).
- Inability to speak and read English.
- Diseases known to affect body fat distribution (e.g., polycystic ovary syndrome, Cushing's syndrome, HIV-AIDS or lipodystrophies).
- Taking medications that may affect body fat distribution (e.g., Thiazolidinedione, Insulin, Growth Hormone).
- Limitations to regular exercise training (e.g., musculoskeletal limitations, heart disease, chronic obstructive pulmonary disease).
- Answering "yes" to any of the questions on the physical activity readiness questionnaire (PAR-Q).
- Having undergone major changes in physical activity, diet or medication in the previous 6 months (or be planning such changes in the next 4 months). Changes in physical activity will be considered as an increase or decrease of more than 1 hour per week. A change in body weight greater 3 kg will also lead to exclusion.
- Body weight \> 300 lbs (maximum weight for Dual Energy X-Ray Absorptiometry (DXA) table).
- HbA1c \> 0.09%
- blood pressure above 140/90 mmHg.
- LDL cholesterol above 3.5 mmol/L or TC:HDL-C above 5.0.
- Self-reported alcohol or substance abuse within the past twelve months, current consumption of more than 14 alcoholic drinks per week, and/or current acute treatment or rehabilitation program for these problems.
- Other medical or psychiatric factors that in the judgment of the principal investigators may interfere with study participation or the ability to follow the study protocol.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01144078
Start Date
June 1 2010
End Date
June 1 2011
Last Update
January 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2H9